Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Clinical and epidemiological characteristics of hepatitis C virus-infected people who inject drugs: a Greek descriptive analysis.

Kranidioti H, Chatzievagelinou C, Protopapas A, Papatheodoridi M, Zisimopoulos K, Evangelidou E, Antonakaki P, Vlachogiannakos J, Triantos C, Elefsiniotis I, Goulis J, Mela M, Anagnostou O, Tsoulas C, Deutsch M, Papatheodoridis G, Manolakopoulos S.

Ann Gastroenterol. 2018 Sep-Oct;31(5):598-603. doi: 10.20524/aog.2018.0293. Epub 2018 Jul 19.

2.

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues.

Papadopoulos N, Papavdi M, Pavlidou A, Konstantinou D, Kranidioti H, Kontos G, Koskinas J, Papatheodoridis GV, Manolakopoulos S, Deutsch M.

Ann Gastroenterol. 2018 May-Jun;31(3):365-370. doi: 10.20524/aog.2018.0255. Epub 2018 Mar 28.

3.

Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.

Deutsch M, Manolakopoulos S, Andreadis I, Giannaris M, Kontos G, Kranidioti H, Pirounaki M, Koskinas J.

Ann Gastroenterol. 2018 Jan-Feb;31(1):77-83. doi: 10.20524/aog.2017.0207. Epub 2017 Oct 26.

4.

KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C.

Naiyer MM, Cassidy SA, Magri A, Cowton V, Chen K, Mansour S, Kranidioti H, Mbirbindi B, Rettman P, Harris S, Fanning LJ, Mulder A, Claas FHJ, Davidson AD, Patel AH, Purbhoo MA, Khakoo SI.

Sci Immunol. 2017 Sep 15;2(15). pii: eaal5296. doi: 10.1126/sciimmunol.aal5296.

PMID:
28916719
5.

Hepatitis B s antigen kinetics during treatment with nucleos(t)ides analogues in patients with hepatitis B e antigen-negative chronic hepatitis B.

Striki A, Manolakopoulos S, Deutsch M, Kourikou A, Kontos G, Kranidioti H, Hadziyannis E, Papatheodoridis G.

Liver Int. 2017 Nov;37(11):1642-1650. doi: 10.1111/liv.13432. Epub 2017 Apr 26.

PMID:
28345181
6.

Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.

Manolakopoulos S, Kranidioti H, Goulis J, Vlachogiannakos J, Elefsiniotis J, Kouroumalis EA, Koskinas J, Kontos G, Evangelidou E, Doumba P, Sinakos E, Vafiadou Ι, Koulentaki M, Papatheodoridis G, Akriviadis E.

Ann Gastroenterol. 2015 Oct-Dec;28(4):481-6.

7.

Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factors.

Kranidioti H, Manolakopoulos S, Khakoo SI.

Ann Gastroenterol. 2015 Apr-Jun;28(2):173-181. Review.

8.

The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Manolakopoulos S, Margariti A, Papageorgiou MV, Kranidioti H, Katoglou A, Kontos G, Adamidi S, Kafiri G, Deutsch M, Pectasides D.

J Viral Hepat. 2014 Jul;21(7):517-24. doi: 10.1111/jvh.12176. Epub 2013 Oct 6.

PMID:
24750382
9.

Elastography for hepatic fibrosis severity in chronic hepatitis B or C.

Papageorgiou MV, Papatheodoridis GV, Manolakopoulos S, Tsochatzis E, Kranidioti H, Kafiri G, Archimandritis AI.

Case Rep Gastroenterol. 2011 Jan 29;5(1):63-72. doi: 10.1159/000316635.

10.

An early circulating factor in severe sepsis modulates apoptosis of monocytes and lymphocytes.

Vaki I, Kranidioti H, Karagianni V, Spyridaki A, Kotsaki A, Routsi C, Giamarellos-Bourboulis EJ.

J Leukoc Biol. 2011 Mar;89(3):343-9. doi: 10.1189/jlb.0410232. Epub 2010 Oct 28.

PMID:
21030664
11.

Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature.

Kanellopoulou T, Filiotou A, Kranidioti H, Dourakis SP.

Clin Rheumatol. 2011 Apr;30(4):581-3. doi: 10.1007/s10067-010-1603-3. Epub 2010 Oct 23. Review.

PMID:
20972592
12.

Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.

Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, Koutoukas P, Kranidioti H, Lignos M, Louis K, Lymberopoulou K, Mainas E, Marioli A, Massouras C, Mavrou I, Mpalla M, Michalia M, Mylona H, Mytas V, Papanikolaou I, Papanikolaou K, Patrani M, Perdios I, Plachouras D, Pistiki A, Protopapas K, Rigaki K, Sakka V, Sartzi M, Skouras V, Souli M, Spyridaki A, Strouvalis I, Tsaganos T, Zografos G, Mandragos K, Klouva-Molyvdas P, Maggina N, Giamarellou H, Armaganidis A, Giamarellos-Bourboulis EJ.

Crit Care. 2010;14(3):R96. doi: 10.1186/cc9031. Epub 2010 May 26.

13.

Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes.

Kranidioti H, Orfanos SE, Vaki I, Kotanidou A, Raftogiannis M, Dimopoulou I, Kotsaki A, Savva A, Papapetropoulos A, Armaganidis A, Giamarellos-Bourboulis EJ.

Immunol Lett. 2009 Jun 30;125(1):65-71. doi: 10.1016/j.imlet.2009.06.006. Epub 2009 Jun 17.

PMID:
19539650
14.

Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study.

Tzepi I, Vergados I, Kanellakopoulou K, Papathanassiou M, Kranidioti H, Tsaganos T, Liarakos V, Giamarellos-Bourboulis EJ, Theodossiadis P.

Int J Antimicrob Agents. 2009 Feb;33(2):160-2. doi: 10.1016/j.ijantimicag.2008.08.010. Epub 2008 Oct 22.

PMID:
18947985
15.

Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect.

Kanellakopoulou K, Pagoulatou A, Stroumpoulis K, Vafiadou M, Kranidioti H, Giamarellou H, Giamarellos-Bourboulis EJ.

J Antimicrob Chemother. 2008 Jun;61(6):1328-31. doi: 10.1093/jac/dkn110. Epub 2008 Mar 18.

PMID:
18353805
16.

Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.

Giamarellos-Bourboulis EJ, Geladopoulos T, Chrisofos M, Koutoukas P, Vassiliadis J, Alexandrou I, Tsaganos T, Sabracos L, Karagianni V, Pelekanou E, Tzepi I, Kranidioti H, Koussoulas V, Giamarellou H.

Shock. 2006 Oct;26(4):410-6.

PMID:
16980890

Supplemental Content

Loading ...
Support Center